United States Cell and Gene Therapy Clinical Trial Services Market Size, Share, and COVID-19 Impact Analysis, By Service (Site Identification, Patient Recruitment, Laboratory Services, Regulatory Services, Supply and Logistic Services, and Others), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Therapeutic Areas (Oncology, Central Nervous System (CNS) Disorders, Cardiovascular Diseases, Infectious Diseases, Musculoskeletal, and Others), By Therapy Type (Gene Therapy, Gene-modified Cell Therapy, and Cell Therapy), and United States Cell and Gene Therapy Clinical Trial Services Market Insights, Industry Trend, Forecasts to 2033

Industry: Healthcare

RELEASE DATE Aug 2024
REPORT ID SI5626
PAGES 210
REPORT FORMAT PathSoft

Request Free Sample

Your personal details will remain secure and confidential - Privacy Policy

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies